Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Production and application of LPA polyclonal antibody.

J H Chen1, F Zou, N D Wang

  • 1Ministry of Education Key Lab of Bioorganic Chemistry & Molecular Engineering, Department of Chemistry, Peking University, Beijing, PR China. jhchem@chemms.chem.pku.edu.cn

Bioorganic & Medicinal Chemistry Letters
|August 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.

Leukemia·2026
Same author

[Platycodin D improves pulmonary fibrosis in mice by down-regulating TRPC6 expression and reducing ROS production in lung fibroblasts].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2024
Same author

[Progress in the clinical research of malignant melanoma in nasal cavity and paranasal sinuses].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2023
Same author

The role of mitochondrial fission in intervertebral disc degeneration.

Osteoarthritis and cartilage·2022
Same author

[Melanocytic eosinophilic metaplasia of nasopharyngeal mucosa: 3 cases report].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2022
Same author

Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: a systematic review and meta-analysis of randomized-controlled trials.

Journal of endocrinological investigation·2021
Same journal

Discovery of a potent sGC stimulator with once-daily dosing potential for the treatment of hypertension.

Bioorganic & medicinal chemistry letters·2026
Same journal

OracleScreen-LILRB4 (HTS-Oracle v3): machine learning-guided discovery of myeloid immune checkpoint binders validated in patient-derived cells.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design and N-terminal acylation of a lactam-cyclized 11-residue antimicrobial peptide for improved antibacterial potency.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design, synthesis, and biological evaluation of chalcone hybrids including benzoylpiperazin (phenylacetylpiperazin)-thiophene as anti- Alzheimer's agents.

Bioorganic & medicinal chemistry letters·2026
Same journal

New aminopiperidine-azoles as antifungal agents against Candida albicans with mechanistic insights into the cAMP-PKA pathway.

Bioorganic & medicinal chemistry letters·2026
Same journal

Novel 1H-pyrrole-2,5-dione derivatives as potential anti-diabetic agents: design, synthesis, in vitro, in ovo, and molecular docking studies.

Bioorganic & medicinal chemistry letters·2026
See all related articles

Researchers developed a new antibody for lysophosphatidic acid (LPA) using colloidal gold. This antibody can detect LPA, potentially aiding in early ovarian cancer diagnosis.

Area of Science:

  • Biotechnology
  • Immunology
  • Oncology

Background:

  • Lysophosphatidic acid (LPA) is a bioactive lipid mediator implicated in various physiological and pathological processes.
  • Elevated LPA levels have been observed in certain cancers, suggesting its potential as a biomarker.
  • Early diagnosis of ovarian cancer remains a significant challenge, necessitating the development of novel detection methods.

Purpose of the Study:

  • To develop a specific antibody for lysophosphatidic acid (LPA).
  • To evaluate the utility of the developed LPA antibody in a diagnostic assay.
  • To explore the potential of LPA detection for early ovarian cancer diagnosis.

Main Methods:

  • Colloidal gold nanoparticles were employed as a hapten carrier for antibody development.

Related Experiment Videos

  • A sensitive dot immunogold filtration assay was established using the anti-LPA antibody.
  • The assay's ability to detect LPA at a clinically relevant concentration was assessed.

    • Main Results:

    • A specific antibody against lysophosphatidic acid (LPA) was successfully generated.
    • The developed antibody enabled the detection of 500 ng/mL of LPA in the dot immunogold filtration assay.
    • The assay demonstrated sensitivity suitable for potential diagnostic applications.

    Conclusions:

    • The developed anti-LPA antibody is a promising tool for LPA detection.
    • This antibody-based assay holds potential for the early diagnosis of ovarian cancer.
    • Further validation is warranted to translate this finding into a clinical diagnostic test.